Boston Scientific (BSX) has been the leader in sales of stents, those little mess tubes that keep arteries open. Recent studies show that the devices are more dangerous than most doctors had…
(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items; estimates were $1.08. Spin-off/sale remains on track. (BLK) Blackrock $1.80 EPS vs…
MONDAYMattel (NYSE:MAT)Novellus (NASDAQ:NVLS)Philips Electronics (NYSE:PHG/ADR)W.W. Grainger (NYSE:GWW) TUESDAYJohnson & Johnson (NYSE:JNJ)Intel Corporation (NASDAQ: INTC)Merrill Lynch (NYSE:MER)Novartis (NYSE:NVS/ADR)Pharmaceutical Product Development (NASDAQ:PPDI)SLM Corp. (NYSE:SLR)State Street (NYSE:STT)Coca Cola (NYSE:KO)Wells fargo (NYSE:WFC)Yahoo! (NASDAQ:YHOO) WEDNESDAYAbbott Labs (NYSE:ABT)Altria…
GE’s (GE) share price has had a bit of a run over the last three months. Until that point, the stock was flat with where it traded in July 2005. Now, two…
According to Reuters, Rio Tinto (RTP) has launched a $38.1 billion takeover bid for Alcan (AL). Reuters writes that customers at JP Morgan have been confused by opposite calls on future plans…
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but…
This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. Cancer stocks in the last few weeks have been seeing a muted…
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is…
